Skip to content

About Us
Research & Development
Vascular Integrity
- Sepsis & Septic Shock
- Adrenomedullin
News & Events
Career

About Us
Research & Development
Vascular Integrity
- Sepsis & Septic Shock
- Adrenomedullin
News & Events
Career

ISICEM 2024 – International Symposium on Intensive Care & Emergency Medicine

18. March 2024

ISICEM 2024 – International Symposium on Intensive Care & Emergency Medicine
18-21 March | Brussels, Belgium

Meet the AdrenoMed team in Brussels

Search for:

Recent News

Journal of Critical Care publishes positive results from prespecified, biomarker-guided subgroup analysis of AdrenoMed’s Phase II AdrenOSS-2 trial in septic shock

20. May 2025

AdrenoMed Receives FDA Fast Track Designation for Enibarcimab for Treatment of Septic Shock

10. April 2024

Adrenomed to attend San Francisco industry and investor conferences

13. December 2023

Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update

8. September 2023

Adrenomed appoints Dr. Stephan Witte as Chief Medical Officer

1. February 2023

Adrenomed to attend upcoming industry and investor conferences

13. October 2022

Media Coverage

Article in The Lancet: On the front lines of the sepsis crisis: hurdles faced by sepsis researchers, survivors, and family advocates

19. December 2024

Article in InVivo: End Game: Adrenomed Targets Global Reach For Sepsis Candidate

2. April 2024

Article in MedNous: Adrenomed prepares global study in septic shock

20. March 2023

Article on LaBiotech: Watch: Adrenomed tackling huge issue of sepsis

19. December 2022

Article in GoingPublic’s Plattform Life Sciences: “A phenomenal breakthrough is taking shape”

4. July 2022

Article in Pink Sheet’s Coronavirus Notebook: UK Adds Paxlovid To PANORAMIC Study, Germany Funds Adrecizumab Phase II Trial

12. April 2022

Recent Events

J.P. Morgan Week & Biotech Showcase 2025 – Meet us in San Francisco

18. December 2024

2024 World Sepsis Day Symposium

28. August 2024

3CT 2024 – Critical Care Clinical Trialists Workshop

13. June 2024

ISICEM 2024 – International Symposium on Intensive Care & Emergency Medicine

18. March 2024

J.P. Morgan Healthcare Conference & Biotech Showcase 2023 – Meet us in San Francisco

9. January 2023

Adrenomed to attend upcoming industry and investor conferences

13. October 2022

More Events

Archive

2025
2024
2023
2022
2021
2020
2019
2018
2017

Contact Info

+49 (0) 3302 20 77 8 0
+49 (0) 3302 20 77 8 15
info@adrenomed.com

ADRENOMED AG

Neuendorfstraße 15A
Hennigsdorf b. Berlin
D-16761, Germany.

Twitter Linkedin

Name

Email

Subject

Message

I agree to the usage and processing of my personal data

By loading the map, you agree to Google's privacy policy.
Learn more

Always unblock Google Maps

PGlmcmFtZSBsb2FkaW5nPSJsYXp5IgoJCQkJCXNyYz0iaHR0cHM6Ly9tYXBzLmdvb2dsZS5jb20vbWFwcz9xPU5ldWVuZG9yZnN0cmElQzMlOUZlJTIwMTVBJTJDJTIwMTY3NjElMjBIZW5uaWdzZG9yZiYjMDM4O3Q9bSYjMDM4O3o9MTUmIzAzODtvdXRwdXQ9ZW1iZWQmIzAzODtpd2xvYz1uZWFyIgoJCQkJCXRpdGxlPSJOZXVlbmRvcmZzdHJhw59lIDE1QSwgMTY3NjEgSGVubmlnc2RvcmYiCgkJCQkJYXJpYS1sYWJlbD0iTmV1ZW5kb3Jmc3RyYcOfZSAxNUEsIDE2NzYxIEhlbm5pZ3Nkb3JmIgoJCQk+PC9pZnJhbWU+

© 2024 AdrenoMed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung | Expanded Access Policy